Quantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitro

Journal of Breath Research

Volumn 8, Issue 4, 2014, Pages

  Mochalski, Paweł ^a   Al Zoairy, Ramona ^b   Niederwanger, Andreas ^c   Unterkofler, Karl ^a,d   Amann, Anton ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Vorarlberg University of Applied Sciences ^*  (Austria)

^d VORARLBERG UNIVERSITY OF APPLIED SCIENCES   (Austria)

Author keywords

enzyme expression; L6 cells; release of VOCs; skeletal muscle; uptake of VOCs; volatile organic compounds

Indexed keywords

ACROLEIN; ALCOHOL DEHYDROGENASE; ALDEHYDE; ALDEHYDE DEHYDROGENASE; CROTONALDEHYDE; HEXANAL; HYDROCARBON; KETONE; PROPIONALDEHYDE; SULFIDE; SULFUR; VALPROIC ACID; VOLATILE ORGANIC COMPOUND;

ALCOHOL METABOLISM; ALGORITHM; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEGRADATION; DRUG HYDROLYSIS; FATTY ACID OXIDATION; GAS CHROMATOGRAPHY; HYDROLYSIS; IN VITRO STUDY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIPID PEROXIDATION; METABOLISM; METHYLATION; MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SKELETAL MUSCLE; TRANSAMINATION; ANIMAL; CELL LINE; CYTOLOGY; EXHALATION; HUMAN; MALE; MASS FRAGMENTOGRAPHY; REPRODUCIBILITY; TIME;

ANIMALS; CELL LINE; EXHALATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIMIT OF DETECTION; MALE; MUSCLE CELLS; MUSCLE, SKELETAL; RATS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VOLATILE ORGANIC COMPOUNDS;

EID: 84910020378     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/8/4/046003     Document Type: Article

References (65)

1. Amann A and Smith D 2005 Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring (Singapore: World Scientific)
2. Amann A and Smith D 2013 Volatile Biomarkers Non-Invasive Diagnosis in Physiology and Medicine ed A Amann and D Smith (Amsterdam: Elsevier)
3. Horvath I and de Jongste J E 2010 Exhaled Biomarkers (European Respiratory Monograph no 49) (Plymouth, UK: European Respiratory Society)
4. Mochalski P, King J, Haas M, Unterkofler K, Amann A and Mayer G 2014 Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease BMC Nephrol. 15 43
5. Mochalski P, King J, Klieber M, Unterkofler K, Hinterhuber H, Baumann M and Amann A 2013 Blood and breath levels of selected volatile organic compounds in healthy volunteers Analyst 138 2134-45
6. de Lacy Costello B, Amann A, Al-Kateb H, Flynn C, Filipiak W, Khalid T, Osborne D and Ratcliffe N M 2014 A review of the volatiles from the healthy human body J. Breath Res. 8 014001
7. Amann A, Mochalski P, Ruzsanyi V, Broza Y Y and Haick H 2014 Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties J. Breath Res. 8 016003
8. Haick H, Broza Y Y, Mochalski P, Ruzsanyi V and Amann A 2014 Assessment, origin, and implementation of breath volatile cancer markers Chem. Soc. Rev. 43 1423-49
9. Amann A, Miekisch W, Schubert J, Buszewski B, Ligor T, Jezierski T, Pleil J and Risby T 2014 Analysis of exhaled breath for disease detection Annu. Rev. Anal. Chem. 7 455-82
10. Filipiak W 2014 Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers J. Breath Res. 8 027111
11. Mochalski P, King J, Kupferthaler A, Unterkofler K, Hinterhuber H and Amann A 2011 Measurement of isoprene solubility in water, human blood and plasma by multiple headspace extraction gas chromatography coupled with solid phase microextraction J. Breath Res. 5 046010
12. Mochalski P, King J, Kupferthaler A, Unterkofler K, Hinterhuber H and Amann A 2012 Human blood and plasma partition coefficients for C4-C8 n-alkanes, isoalkanes, and 1-alkenes Int. J. Toxicol. 31 267-75
13. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2010 TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro Cancer Epidemiol. Biomarkers Prev. 19 182-95
14. Filipiak W, Sponring A, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2008 Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro Cancer Cell Int. 8 17
15. Sponring A, Filipiak W, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2010 Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells Cancer Biomarkers 7 153-61
16. Sponring A, Filipiak W, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2009 Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro Anticancer Res. 29 419-26
17. Mochalski P, Sponring A, King J, Unterkofler K, Troppmair J and Amann A 2013 Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro Cancer Cell Int. 13 72
18. Filipiak W, Sponring A, Baur M M, Ager C, Filipiak A, Wiesenhofer H, Nagl M, Troppmair J and Amann A 2012 Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS Microbiology 158 3044-53 (Part 12)
19. Filipiak W, Sponring A, Baur M M, Filipiak A, Ager C, Wiesenhofer H, Nagl M, Troppmair J and Amann A 2012 Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa BMC Microbiol. 12 113
20. Filipiak W, Sponring A, Filipiak A, Baur M, Ager C, Wiesenhofer H, Margesin R, Nagl M, Troppmair J and Amann A 2013 Volatile organic compounds (VOCs) released by athogenic microorganisms in vitro: potential breath biomarkers for early-stage diagnosis of disease Volatile Biomarkers: Non-Invasive Diagnosis in Physiology and Medicine ed A Amann (Amsterdam: Elsevier)
21. Calenic B, Filipiak W, Greabu M and Amann A 2013 Volatile organic compounds expression in different cell types an in vitro approach Int. J. Clin. Toxicol. 1 43-51
22. Yuzefovych L V, LeDoux S P, Wilson G L and Rachek L I 2013 Mitochondrial DNA damage via augmented oxidative stress regulates endoplasmic reticulum stress and autophagy: crosstalk, links and signaling PLoS One 8 e83349
23. Kranebitter M, Niederwanger A, Tatarczyk T, Ciardi C, Al-Zoairy R, Patsch J R and Pedrini M T 2010 Pioglitazone has direct effects on insulin sensitivity and intracellular lipid content in L6 skeletal muscle cells Horm. Metab. Res. 42 987-90
24. Huber W 2003 Basic calculations about the limit of detection and its optimal determination Accreditation Qual. Assur. 8 213-17
25. Crabb D W, Matsumoto M, Chang D and You M 2004 Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology Proc. Nutr. Soc. 63 49-63
26. Klyosov A A 1996 Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes Biochemistry 35 4457-67
27. Nilsson G E 1988 A comparative study of aldehyde dehydrogenase and alcohol dehydrogenase activities in crucian carp and three other vertebrates: apparent adaptations to ethanol production J. Comput. Physiol. B 158 479-85
28. Stewart M J, Malek K and Crabb D W 1996 Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues J. Investig. Med. 44 42-6
29. Sladek N E 2003 Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact J. Biochem. Mol. Toxicol. 17 7-23
30. Jean E, Laoudj-Chenivesse D, Notarnicola C, Rouger K, Serratrice N, Bonnieu A, Gay S, Bacou F, Duret C and Carnac G 2011 Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells J. Cell Mol. Med. 15 119-33
31. Julia P, Farres J and Pares X 1987 Characterization of three isoenzymes of rat alcohol dehydrogenase. Tissue distribution and physical and enzymatic properties Eur. J. Biochem. 162 179-89
32. Mendoza C E, Shields J B and Phillips W E 1971 Distribution of carboxylesterase activities in different tissues of albino rats Comput. Biochem. Physiol. B 40 841-54
33. Satoh T and Hosokawa M 1998 The mammalian carboxylesterases: from molecules to functions Annu. Rev. Pharmacol. Toxicol. 38 257-88
34. Imai T 2006 Human carboxylesterase isozymes: catalytic properties and rational drug design Drug Metab. Pharmacokinet. 21 173-85
35. Ditlow C C, Holmquist B, Morelock M M and Vallee B L 1984 Physical and enzymatic properties of a class II alcohol dehydrogenase isozyme of human liver: pi-ADH Biochemistry 23 6363-8
36. Serve M P, Bombick D D, Baughman T M, Jarnot B M, Ketcha M and Mattie D R 1995 The metabolism of n-nonane in male Fischer-344 rats Chemosphere 31 2661-8
37. Edwards J E, Rose R L and Hodgson E 2005 The metabolism of nonane, a JP-8 jet fuel component, by human liver microsomes, P450 isoforms and alcohol dehydrogenase and inhibition of human P450 isoforms by JP-8 Chem. Biol. Interact. 151 203-11
38. Erhart S et al 2009 3-Heptanone as a potential new marker for valproic acid therapy J. Breath Res. 3 016004
39. Walker V and Mills G A 2001 Urine 4-heptanone: a beta-oxidation product of 2-ethylhexanoic acid from plasticisers Clin. Chim. Acta 306 51-61
40. Hanai Y, Shimono K, Oka H, Baba Y, Yamazaki K and Beauchamp G K 2012 Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice Cancer Cell Int. 12 7
41. Tangerman A 2009 Measurement and biological significance of the volatile sulfur compounds hydrogen sulfide, methanethiol and dimethyl sulfide in various biological matrices J. Chromatogr. B 877 3366-77
42. Velikova V B 2008 Isoprene as a tool for plant protection against abiotic stresses J. Plant Interact. 3 1-15
43. Sharkey T D and Yeh S 2001 Isoprene emission from plants Annu. Rev. Plant Physiol. Plant Mol. Biol. 52 407-36
44. Wagner W P, Helmig D and Fall R 2000 Isoprene biosynthesis in Bacillus subtilis via the methylerythritol phosphate pathway J. Nat. Prod. 63 37-40
45. Fall R and Copley S D 2000 Bacterial sources and sinks of isoprene, a reactive atmospheric hydrocarbon Environ. Microbiol. 2 123-30
46. Cailleux A, Cogny M and Allain P 1992 Blood isoprene concentrations in humans and in some animal species Biochem. Med. Metab. Biol. 47 157-60
47. Kushch I 2008 Breath isoprene - aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study Clin. Chem. Lab. Med. 46 1011-8
48. Rasmussen L E and Perrin T E 1999 Physiological correlates of musth: lipid metabolites and chemical composition of exudates Physiol. Behav. 67 539-49
49. Jomaa H et al 1999 Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs Science 285 1573-6
50. Silver G M and Fall R 1991 Enzymatic synthesis of isoprene from dimethylallyl diphosphate in aspen leaf extracts Plant Physiol. 97 1588-91
51. Deneris E S, Stein R A and Mead J F 1985 Acid-catalyzed formation of isoprene from a mevalonate-derived product using a rat liver cytosolic fraction J. Biol. Chem. 260 1382-5
52. King J, Mochalski P, Unterkofler K, Teschl G, Klieber M, Stein M, Amann A and Baumann M 2012 Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body Biochem. Biophys. Res. Commun. 423 526-30
53. McGrath L T, Patrick R and Silke B 2001 Breath isoprene in patients with heart failure Eur. J. Heart Fail. 3 423-7
54. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, Teschl S, Hinterhuber H and Amann A 2010 Physiological modeling of isoprene dynamics in exhaled breath J. Theor. Biol. 267 626-37
55. Salerno-Kennedy R and Cashman K D 2005 Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview Wien Klin. Wochenschr. 117 180-6
56. Kneepkens C M, Lepage G and Roy C C 1994 The potential of the hydrocarbon breath test as a measure of lipid peroxidation Free Radic. Biol. Med. 17 127-60
57. Phillips M, Cataneo R N, Greenberg J, Grodman R, Gunawardena R and Naidu A 2003 Effect of oxygen on breath markers of oxidative stress Eur. Respir. J 21 48-51
58. Aghdassi E, Wendland B E, Steinhart A H, Wolman S L, Jeejeebhoy K and Allard J P 2003 Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial Am. J. Gastroenterol. 98 348-53
59. Aghdassi E and Allard J P 2000 Breath alkanes as a marker of oxidative stress in different clinical conditions Free Radic. Biol. Med. 28 880-6
60. Dillard C J, Dumelin E E and Tappel A L 1977 Effect of dietary vitamin E on expiration of pentane and ethane by the rat Lipids 12 109-14
61. Dumelin E E and Tappel A L 1977 Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides Lipids 12 894-900
62. Frankel E N 1980 Lipid oxidation Prog. Lipid Res. 19 1-22
63. Powers S K, Kavazis A N and McClung J M 1985 Oxidative stress and disuse muscle atrophy J. Appl. Physiol. 102 2389-97
64. Kondo H, Nakagaki I, Sasaki S, Hori S and Itokawa Y 1993 Mechanism of oxidative stress in skeletal muscle atrophied by immobilization Am. J. Physiol. 265 E839-44 (Part 1)
65. Vickers C E, Gershenzon J, Lerdau M T and Loreto F 2009 A unified mechanism of action for volatile isoprenoids in plant abiotic stress Nature Chem. Biol. 5 283-91